I hear you don't worry. Several of my posts have been on the valuation models too of the product. The best I can deduce is that there should be 600 E profit for each product sold. Still a healthy margin in any language. For me the real kicker is going to be the FDA approval mid next year. USA is a HUGE market as we know. And as someone has alluded to - the more we make the less per unit cost. All bodes well.
Neurotech Investor Roadshow 2016, page-22
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
